Posted in | News | Nanomaterials | Nanoanalysis

Silvaco ATLAS Device Adopted for Silicon Nanowire Solar Cell Simulations by Tokyo Institute of Technology

Silvaco Japan Co., Ltd. (Silvaco) has announced that it has won a competitive bid to have its ATLAS device simulator used for the development of silicon nanowire solar cells from the Konagai and Miyajima Laboratory in the Tokyo Institute of Technology. Silvaco's ATLAS simulation software will be used at the Fukushima Top-level United center for Renewable Energy research - PhotoVoltaics Innovation (FUTURE-PV) project with additional support provided by the Japan Science and Technology Agency (JST).

ATLAS is widely used by many companies, universities, and research and development centers as it enables reliable simulations for many different devices, and provides 2D and 3D electrical, optical and thermal physical models needed for accurate simulation of solar cells. Konagai and Miyajima Lab is a leading developer of solar cells, and predictable simulations are indispensable to the design of new and optimized solar cell structures.

Shinsuke Miyajima, Associate Professor of Konagai and Miyajima Lab, said, "ATLAS includes many functions required for silicon nanowire solar cell simulations, especially in the field of quantum effects. Modeling these quantum effects is critical for the development of advanced technology devices such as silicon nanowires. We are confident that ATLAS will help speed up our development program."

"We are pleased with the adoption of ATLAS in this nationally important project," said David Halliday, CEO of Silvaco. "We believe the use of ATLAS will accelerate this leading edge research, and we are proud that Silvaco continues to contribute to important projects such as this."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.